PH17460A - Hydantoin derivatives and pharmaceutical compositions containing the same - Google Patents
Hydantoin derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- PH17460A PH17460A PH25947A PH25947A PH17460A PH 17460 A PH17460 A PH 17460A PH 25947 A PH25947 A PH 25947A PH 25947 A PH25947 A PH 25947A PH 17460 A PH17460 A PH 17460A
- Authority
- PH
- Philippines
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- hydantoin derivatives
- hydantoin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55098695A JPS5745185A (en) | 1980-07-21 | 1980-07-21 | Hydantoin derivative and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
PH17460A true PH17460A (en) | 1984-08-29 |
Family
ID=14226632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH25947A PH17460A (en) | 1980-07-21 | 1981-07-21 | Hydantoin derivatives and pharmaceutical compositions containing the same |
Country Status (14)
Country | Link |
---|---|
US (3) | US4540704A (de) |
JP (1) | JPS5745185A (de) |
BE (1) | BE889698A (de) |
CA (1) | CA1167447A (de) |
CH (1) | CH651568A5 (de) |
DE (1) | DE3128606A1 (de) |
DK (1) | DK157301C (de) |
ES (1) | ES504103A0 (de) |
FR (1) | FR2487353B1 (de) |
GB (1) | GB2080304B (de) |
IT (1) | IT1194143B (de) |
NL (1) | NL8103432A (de) |
PH (1) | PH17460A (de) |
SE (1) | SE454778B (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4556670A (en) * | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
GB2132484B (en) * | 1982-12-23 | 1986-07-02 | Tampax Ltd | Tampon applicator |
US4474967A (en) * | 1983-04-27 | 1984-10-02 | Pfizer Inc. | 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione |
ATE37371T1 (de) * | 1984-08-20 | 1988-10-15 | Pfizer | Verfahren zur herstellung asymmetrischer hydantoine. |
US5066659A (en) * | 1984-10-30 | 1991-11-19 | Pfizer Inc. | Spiro-heteroazalones for treatment of diabetic complications |
JPS62155269A (ja) * | 1984-12-29 | 1987-07-10 | Kaken Pharmaceut Co Ltd | ベンゾフラン誘導体 |
JPH0772190B2 (ja) * | 1985-02-26 | 1995-08-02 | エーザイ株式会社 | ヒダントイン誘導体 |
JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
US4762839A (en) * | 1985-06-06 | 1988-08-09 | Tanabe Seiyaku Co., Ltd. | Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications |
WO1987004344A1 (en) * | 1986-01-17 | 1987-07-30 | Pfizer Inc. | Hydroxyacetic acid derivatives for the treatment of diabetic complications |
EP0264586B1 (de) * | 1986-08-28 | 1991-04-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | Hydantoin-Derivate zur Behandlung von Komplikationen bei Diabetes |
JPS6357588A (ja) * | 1986-08-28 | 1988-03-12 | Sanwa Kagaku Kenkyusho Co Ltd | ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤 |
JPS63132889A (ja) * | 1986-11-21 | 1988-06-04 | Tanabe Seiyaku Co Ltd | キナゾリノン誘導体 |
US4841079A (en) * | 1987-08-07 | 1989-06-20 | Pfizer, Inc. | Process for the production of asymmetric hydantoins |
JP2708507B2 (ja) * | 1988-04-07 | 1998-02-04 | 株式会社三和化学研究所 | (d)‐6‐フルオロ‐2,3‐ジヒドロ‐2’,5’‐ジオキソ‐スピロ[4H‐1‐ベンゾピラン‐4,4’‐イミダゾリジン]‐2‐カルボキサミド誘導体、これらの製法及び用途 |
US4987231A (en) * | 1989-08-04 | 1991-01-22 | Pfizer Inc. | Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol |
US5164391A (en) * | 1989-09-20 | 1992-11-17 | Sanwa Kagaku Kenkyusho Co., Ltd. | Hydantoin derivatives for treating complications of diabetes and circulatory diseases |
US4980357A (en) * | 1990-03-01 | 1990-12-25 | Pfizer Inc. | Azolidinedione derivatives |
WO1993005045A1 (en) * | 1991-08-28 | 1993-03-18 | The Upjohn Company | Spirocyclic benzopyran imidazolines |
GB9312853D0 (en) * | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
US5591776A (en) * | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
US6539336B1 (en) * | 1996-12-12 | 2003-03-25 | Phatrat Technologies, Inc. | Sport monitoring system for determining airtime, speed, power absorbed and other factors such as drop distance |
US7386401B2 (en) * | 1994-11-21 | 2008-06-10 | Phatrat Technology, Llc | Helmet that reports impact information, and associated methods |
US6166041A (en) * | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
US6075016A (en) * | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
JP3553086B2 (ja) * | 1997-04-15 | 2004-08-11 | シーエスアイアール | 食欲抑制活性を有する医薬組成物 |
US6077849A (en) * | 1998-04-02 | 2000-06-20 | Merck & Co., Inc. | Antidiabetic agents |
AU754989B2 (en) * | 1998-11-16 | 2002-11-28 | Nippon Zoki Pharmaceutical Co., Ltd. | A therapeutic agent for intractable vasculitis |
GB2355657B (en) * | 1999-10-27 | 2004-07-28 | Phytopharm Plc | Inhibitors Of Gastric Acid Secretion |
GB2363985B (en) * | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
EA200300433A1 (ru) | 2000-11-30 | 2003-10-30 | Пфайзер Продактс Инк. | Комбинация гамк-агонистов и ингибиторов альдегидредуктазы |
US20110092566A1 (en) * | 2004-11-19 | 2011-04-21 | Srivastava Satish K | Treatment of cancer with aldose reductase inhibitors |
US8158667B2 (en) | 2006-08-21 | 2012-04-17 | Kador Peter F | Topical treatment of cataracts in dogs |
ES2371393T3 (es) | 2007-03-12 | 2011-12-30 | Zadec Aps | Extracto antidiabético de rooibos. |
EP2848252A3 (de) | 2007-03-23 | 2015-06-17 | The Board of Regents of the University of Texas System | Aldose-Reduktase-Inhibitoren zur Behandlung von Uveitis |
US20090270490A1 (en) * | 2008-04-24 | 2009-10-29 | The Board Of Regents Of The University Of Texas System | Methods involving aldose reductase inhibition |
WO2010065024A1 (en) * | 2008-12-05 | 2010-06-10 | Kador Peter F | Topical treatment of cataracts in dogs |
NZ594230A (en) | 2009-03-13 | 2013-11-29 | Vitae Pharmaceuticals Inc | Inhibitors of beta-secretase |
EP2539322B1 (de) | 2010-02-24 | 2014-01-01 | Vitae Pharmaceuticals, Inc. | Beta-sekretase-hemmer |
EP2654749B1 (de) | 2010-12-23 | 2017-05-10 | The Board of Regents of The University of Texas System | Verfahren zur behandlung von copd |
TWI557112B (zh) | 2012-03-05 | 2016-11-11 | 百靈佳殷格翰國際股份有限公司 | β-分泌酶抑制劑 |
TW201422592A (zh) | 2012-08-27 | 2014-06-16 | Boehringer Ingelheim Int | β-分泌酶抑制劑 |
EP2900650A1 (de) | 2012-09-28 | 2015-08-05 | Vitae Pharmaceuticals, Inc. | Beta-sekretase-hemmer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US418729A (en) * | 1890-01-07 | Cultivator | ||
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4147795A (en) * | 1977-02-11 | 1979-04-03 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
US4176185A (en) * | 1979-01-22 | 1979-11-27 | Pfizer Inc. | Spiro-quinolylhydantoins |
US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
FR2455046A1 (fr) * | 1979-04-25 | 1980-11-21 | Science Union & Cie | Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament |
-
1980
- 1980-07-21 JP JP55098695A patent/JPS5745185A/ja active Granted
-
1981
- 1981-07-17 CH CH4717/81A patent/CH651568A5/de not_active IP Right Cessation
- 1981-07-20 ES ES504103A patent/ES504103A0/es active Granted
- 1981-07-20 DK DK323281A patent/DK157301C/da not_active IP Right Cessation
- 1981-07-20 DE DE19813128606 patent/DE3128606A1/de active Granted
- 1981-07-20 SE SE8104456A patent/SE454778B/sv not_active IP Right Cessation
- 1981-07-20 IT IT23026/81A patent/IT1194143B/it active
- 1981-07-20 NL NL8103432A patent/NL8103432A/nl not_active Application Discontinuation
- 1981-07-21 GB GB8122450A patent/GB2080304B/en not_active Expired
- 1981-07-21 CA CA000382174A patent/CA1167447A/en not_active Expired
- 1981-07-21 FR FR8114165A patent/FR2487353B1/fr not_active Expired
- 1981-07-21 PH PH25947A patent/PH17460A/en unknown
- 1981-07-22 BE BE0/205464A patent/BE889698A/fr not_active IP Right Cessation
-
1983
- 1983-06-07 US US06/500,801 patent/US4540704A/en not_active Expired - Fee Related
-
1987
- 1987-07-13 US US07/073,915 patent/US4874869A/en not_active Expired - Fee Related
- 1987-11-02 US US07/117,887 patent/US4780472A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
SE8104456L (sv) | 1982-01-22 |
DE3128606C2 (de) | 1992-04-23 |
DK157301C (da) | 1990-05-07 |
JPS6332793B2 (de) | 1988-07-01 |
NL8103432A (nl) | 1982-02-16 |
DK157301B (da) | 1989-12-04 |
CA1167447A (en) | 1984-05-15 |
FR2487353A1 (fr) | 1982-01-29 |
ES8205398A1 (es) | 1982-06-01 |
US4780472A (en) | 1988-10-25 |
SE454778B (sv) | 1988-05-30 |
US4540704A (en) | 1985-09-10 |
FR2487353B1 (fr) | 1986-03-07 |
DE3128606A1 (de) | 1982-05-13 |
GB2080304B (en) | 1984-02-01 |
BE889698A (fr) | 1982-01-22 |
IT8123026A0 (it) | 1981-07-20 |
ES504103A0 (es) | 1982-06-01 |
JPS5745185A (en) | 1982-03-13 |
IT1194143B (it) | 1988-09-14 |
GB2080304A (en) | 1982-02-03 |
CH651568A5 (de) | 1985-09-30 |
DK323281A (da) | 1982-02-26 |
US4874869A (en) | 1989-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH17460A (en) | Hydantoin derivatives and pharmaceutical compositions containing the same | |
PH18015A (en) | Antifungal bis-triazole derivatives and pharmaceutical compositions containing them | |
PH24267A (en) | Androstane carbothioates and pharmaceutical compositions containing the same | |
MY8600029A (en) | 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing themn | |
PH22014A (en) | Heterocyclic derivatives and pharmaceutical compositions containing the same | |
IL63576A0 (en) | Imidazole derivatives,their manufacture and pharmaceutical compositions containing them | |
IL72566A (en) | Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same | |
NZ201520A (en) | Substituted aminopyridazines and pharmaceutical compositions | |
IL61930A (en) | 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it | |
IL62039A0 (en) | Imidazoline derivative,processes for the preparation thereof and pharmaceutical compositions containing the same | |
DE3168067D1 (en) | 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them | |
GB2088373B (en) | Dibenzazepine derivatives and pharmaceutical compositions containing them | |
PH20168A (en) | 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions | |
PH21540A (en) | Cholecalciferol derivatives and pharmaceutical compositions containing the same | |
IL64054A (en) | Imidazolylpyridines and pharmaceutical compositions containing them | |
DE3265871D1 (en) | 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives and pharmaceutical composition containing the same | |
PH18532A (en) | Novel carbostyril derivatives and pharmaceutical compositions containing the same | |
IL70189A (en) | 2-piperazinyl-quinazoline derivatives,their proeuction and pharmaceutical compositions containing them | |
NZ205732A (en) | Thiatriazine derivatives and pharmaceutical compositions | |
DE3364055D1 (en) | Thiophene derivatives and fungicidal composition containing the same | |
GB2079285B (en) | Dipthosphonate derivatives and pahrmaceutical compositions containing them | |
NZ203649A (en) | 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions | |
PH16754A (en) | Novel acylamino-benzazole derivatives,and pharmaceutical composition containing same | |
IL68448A0 (en) | 4-phenoxy and 4-phenylthio proline derivatives and pharmaceutical compositions containing the same | |
IL57436A0 (en) | Hydantoin derivatives and pharmaceutical compositions containing them |